Organization · Venture Capital
晟德（TWO：4123）Center Ventures
Center Ventures is a Taiwanese biotechnology investment firm that focuses on supporting biotech and health companies in reaching international markets. It operates as an incubator and investor across various sectors within the biotechnology industry.
Overview
What 晟德（TWO：4123）Center Ventures does
What 晟德（TWO：4123）Center Ventures is
Center Ventures is a Taiwanese biotechnology investment firm that focuses on supporting biotech and health companies in reaching international markets. It operates as an incubator and investor across various sectors within the biotechnology industry.
How it participates in the startup ecosystem
The current public profile supports funder and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder · Event host
- Last reviewed
- April 24, 2026
Official channels
Find 晟德（TWO：4123）Center Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
晟德（TWO：4123）Center Ventures as a funder
Investment thesis
晟德 Center Ventures focuses on supporting biotech and health companies to reach international markets through an operator/incubator model, covering the full biotech value chain.
Focus narrative
The organization invests across various sectors within the biotechnology and health industries, including drug development, protein and antibody drug development, health products, agricultural biotechnology, and medical devices. Their investment strategy emphasizes nurturing companies with significant growth potential and facilitating their international expansion.
Value beyond capital
晟德 Center Ventures adds value to its portfolio companies through its extensive network, industry expertise, and resources aimed at facilitating international market entry and growth. The organization also runs a talent training camp to nurture young professionals in the biotech industry, further enhancing the ecosystem.
Focus and fit
- Stages
- Seed · Growth Equity
- Regions
- Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
- Recorded notable exits
- Center Laboratories Inc., Mycenax Biotech, KriSan Biotech, Glac Biotech, and Lumosa
Portfolio context
Notable portfolio companies include: 澳優乳業 (AUSNUTRIA): A leading infant formula company listed in Hong Kong, focusing on high-quality nutritional products. 東曜藥業 (EirGenix): A biopharmaceutical company specializing in antibody-drug conjugates (ADCs) and other innovative therapies. 順天醫藥 (Lumosa): A company focused on developing new drugs for pain management and other therapeutic areas. 永昕生醫 (Mycenax): A company providing contract development and manufacturing organization (CDMO) services for biopharmaceuticals. 豐華生技 (Glac): A company specializing in probiotics and health products.
Capability profile
晟德（TWO：4123）Center Ventures as an event host
Event focus
晟德（TWO：4123）Center Ventures focuses on investing in various sectors within biotechnology and health, including drug development, protein and antibody drug development, health products, agricultural biotechnology, and medical devices. Their investment strategy emphasizes nurturing companies with significant growth potential and facilitating their international expansion.
Participant value
The organization provides a robust platform for biotech companies to access funding, mentorship, and resources necessary for growth and international market entry.
Format and cadence
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Seed · Growth Equity
- Audience
- Founders · Investors · Students
- Regions
- Asia
Common questions
What to know about 晟德（TWO：4123）Center Ventures
Upseed classifies 晟德（TWO：4123）Center Ventures under the Venture Capital organization type. Its current public profile includes funder and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.